Current cannabis use was “consistently associated with smaller waist circumference, lower BMI, and lower risks of … obesity in patients with chronic HCV infection.”
Archives: News Releases
Since 1992, every Thursday and when breaking news warrants, NORML | The NORML Foundation have been issuing weekly press releases for marijuana law supporters and the media.
NORML’s News Releases archives goes back to 1996 and serves as a valuable tool to alert citizens about cannabis-related news and legislation as well as a research tool for reviewing a chronology of marijuana law reform.
Authors theorized that more frequent consumers were more tolerant to the effects of cannabis and also engaged in more compensatory driving behaviors.
“Extending our results to other states, we find that medical cannabis legalization has reduced auto insurance premiums by $1.5 billion in all states that have currently legalized,” authors concluded.
Investigators concluded: “[M]ost cancer comorbid symptoms improved significantly during six months of medical cannabis treatment.”
Compared to the placebo group, subjects receiving CBD extracts experienced significant improvements in their ASD symptoms.
Compared to non-users, those who consumed cannabis were more likely to be younger and were more likely to report suffering from severe pain.
Judges opined that the process used to manufacture the end product was irrelevant as long as it was initially sourced from either hemp or hemp-derived CBD.
Authors concluded: “[A]cute, oral CBD treatment at doses up to 1500 mg does not induce feelings of intoxication and is unlikely to impair cognitive function or driving performance.”